At a Glance
- Tasks: Lead late-stage development programmes and drive FDA readiness for rare diseases.
- Company: Cycle Pharmaceuticals, a pioneering company in rare disease research.
- Benefits: Hybrid work model, competitive salary, and opportunities for professional growth.
- Other info: Join a dynamic team dedicated to transforming rare disease treatment.
- Why this job: Make a real difference in patients' lives through innovative R&D strategies.
- Qualifications: Proven experience in R&D and regulatory strategy in the pharmaceutical industry.
The predicted salary is between 85500 - 104500 $ per year.
Cycle Pharmaceuticals, headquartered in Cambridge, UK, is seeking an accomplished Director of Research & Development.
This full-time role, based in our Cambridge office on a hybrid basis (minimum 3 days in the office), reports to the Chief Strategy Officer.
You will own late-stage development programmes from strategy through execution and regulatory submission, driving FDA readiness and patient impact.
Build and lead a high-performing, cross-functional R&D team across Product Development,
Director, Rare Disease R&D & Regulatory Strategy in Cambridge employer: Cycle Pharmaceuticals
Cycle Pharmaceuticals is dedicated to making a meaningful impact in the field of rare diseases, with a strong focus on oncology, hematology, neurology, and rare metabolic conditions. The company fosters a collaborative work environment that emphasizes professional growth and the importance of every patient. Employees benefit from hybrid working arrangements and the opportunity to contribute to innovative pharmaceutical development.
